VECO Form 4: SVP Sold 4,046 Shares at $26 — Insider Filing
Insider sale reported: Veeco Instruments SVP Adrian Devasahayam sold 4,046 shares of Veeco common stock on 09/15/2025 at $26.00 per share, reducing his beneficial ownership to 86,134.208 shares.
Rhea-AI Filing Summary
Insider sale reported: Veeco Instruments SVP Adrian Devasahayam sold 4,046 shares of Veeco common stock on 09/15/2025 at $26.00 per share, reducing his beneficial ownership to 86,134.208 shares. The Form 4 was signed by an attorney-in-fact on 09/16/2025.
Positive
- Timely disclosure of the insider sale via Form 4, filed and signed by attorney-in-fact
- Clear transaction details: 4,046 shares sold at $26.00, with resulting beneficial ownership stated
Negative
- Reduction in officer's holdings to 86,134.208 shares following the sale
Insights
TL;DR: An officer sale of a small number of shares; likely immaterial to company valuation.
The reported sale of 4,046 shares at $26 reduces the reporting officer's holdings to 86,134.208 shares. The transaction is a direct disposition and is disclosed on a timely Form 4, indicating compliance with Section 16 reporting. The size of the sale appears modest relative to common equity outstanding, suggesting limited market impact.
TL;DR: Transaction shows transparent insider reporting; no governance red flags in the filing itself.
The Form 4 documents an officer-level sale executed and reported, with an attorney-in-fact signature. There is no indication of related-party issues, option exercises, or derivative transactions in this filing. The disclosure meets filing requirements and contains no corrective amendments.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 4,046 | $26.00 | $105K |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Veeco (VECO) report on this Form 4?
Was the Form 4 signed and when?
Does the filing show any derivative transactions or option exercises?
AI-generated analysis. How Rhea-AI works. Not financial advice.